up to fight cancer
the first round of appointments, Dennis Matthews, a physicist and
leader of the Medical Technology Program at Lawrence Livermore,
was appointed associate director of biomedical technology for the
UC Davis Cancer Center. Jim Felton, a Livermore specialist in cancer
causation and prevention, was tagged to be associate director of
cancer control. Ken Turteltaub, leader of the lab's molecular toxicology
team, was named co-leader of the UC Davis Cancer Center program
in molecular oncology.
wide ranging, open-ended partnership "brings together researchers
from two entirely different cultures: the scientists of Lawrence
Livermore with the patient-centered clinical researchers of the
cancer center," said deVere White.
are basic scientists at Lawrence Livermore National Laboratory who
have all the tools but who don't know what the medical problems
are," added John Boone, a UC Davis professor of radiology and
co-leader of the cancer center's biomedical technology program.
"Our physicians know the problems but don't know what technological
solutions are available to them."
the ultimate research potluck. UC Davis researchers bring expertise
in molecular pharmacology, animal biology, biochemistry, DNA repair
and clinical cancer research. Lawrence Livermore scientists have
strengths in biotechnology, physics, and carcinogenesis.
Table of Contents |
To our Readers |
Building on Basics
Focusing on Patients |
In Translation |
Campus Connection |
News in Brief
UC Davis Health System |
© 2000, 2001, 2002 UC Regents. All rights reserved.
left, Lawrence Livermore's Jim Felton, Ken Turteltaub and Dennis
Matthews inside the Center for Accelerator Mass Spectrometry.